Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01054027 · ClinicalTrials.gov registry record · NA
Study on Effective Mydriasis in Premature Infants
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01054027 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 15 participants.
The verdict
NCT01054027, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the dilating effect of 0, 1, 2 or 3 drops of mydriatic (pupil dilating) in premature infants undergoing routine retinal (eye) screening exams for Retinopathy of Prematurity (ROP).
Interventions
- DRUG 1% phenylephrine and 0.2% cyclopentolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01054027
The ClinicalTrials.gov registry entry for NCT01054027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1% phenylephrine and 0.2% cyclopentolate is the first listed.
NCT01054027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01054027 about?
NCT01054027 is a clinical study titled "Study on Effective Mydriasis in Premature Infants". The purpose of this study is to compare the dilating effect of 0, 1, 2 or 3 drops of mydriatic (pupil dilating) in premature infants undergoing routine retinal (eye) screening exams for Retinopathy of Prematurity (ROP).
What is the current status of trial NCT01054027?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2007-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT01054027?
The interventions under investigation include: 1% phenylephrine and 0.2% cyclopentolate (DRUG).
Who is sponsoring clinical trial NCT01054027?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.